Contact
Please use this form to send email to PR contact of this press release:
European Commission approves second indication of Sarclisa® (isatuximab) for relapsed multiple myeloma
TO:
Please use this form to send email to PR contact of this press release:
European Commission approves second indication of Sarclisa® (isatuximab) for relapsed multiple myeloma
TO: